Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2017

Content (25 Articles)

Review

Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response?

Orit Kaidar-Person, Timothy M. Zagar, Jorge Daniel Oldan, Jason Matney, Ellen L. Jones, Shiva Das, Brian C. Jensen, Richard C. Zellars, Terence Z. Wong, Lawrence B. Marks

Review

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

Jessica A. Cintolo-Gonzalez, Danielle Braun, Amanda L. Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K. Plichta, Molly Griffin, Kevin S. Hughes

Review

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia

Alvaro Peña, Sejal S. Shah, Robert T. Fazzio, Tanya L. Hoskin, Rushin D. Brahmbhatt, Tina J. Hieken, James W. Jakub, Judy C. Boughey, Daniel W. Visscher, Amy C. Degnim

Preclinical study

Image analysis of immune cell patterns in the human mammary gland during the menstrual cycle refines lymphocytic lobulitis

Nadine S. Schaadt, Juan Carlos López Alfonso, Ralf Schönmeyer, Anne Grote, Germain Forestier, Cédric Wemmert, Nicole Krönke, Mechthild Stoeckelhuber, Hans H. Kreipe, Haralampos Hatzikirou, Friedrich Feuerhake

Open Access Preclinical study

Phenotypic characterisation of breast cancer: the role of CDC42

Eleni Chrysanthou, Kylie L. Gorringe, Chitra Joseph, Madeleine Craze, Christopher C. Nolan, Maria Diez-Rodriguez, Andrew R. Green, Emad A. Rakha, Ian O. Ellis, Abhik Mukherjee

Preclinical study

Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells

Jie Yuan, Yi Yang, Zicong Gao, Zhiyong Wang, Wei Ji, Weijie Song, Fei Zhang, Ruifang Niu

Open Access Preclinical study

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections

Abir A. Muftah, Mohammed A. Aleskandarany, Methaq M. Al-kaabi, Sultan N. Sonbul, Maria Diez-Rodriguez, Chris C. Nolan, Carlos Caldas, Ian O. Ellis, Emad A. Rakha, Andrew R. Green

Preclinical study

Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3

Brittany Turner-Ivey, Ericka L. Smith, Alex C. Rutkovsky, Laura S. Spruill, Jamie N. Mills, Stephen P. Ethier

Clinical trial

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, Julia Osburg, Brigitte Storch-Hagenlocher, Serkan Sertel, Michael Elsässer, Bjoern Andrew Remppis, Lutz Edler, Judith Munzinger, Thomas Efferth, Andreas Schneeweiss, Thomas Strowitzki

Clinical trial

Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32

Ana Elisa Lohmann, Mira F. Liebman, William Brien, Wendy R. Parulekar, Karen A. Gelmon, Lois E. Shepherd, Jennifer A. Ligibel, Dawn L. Hershman, Priya Rastogi, Ingrid A. Mayer, Timothy J. Hobday, Julie Lemieux, Alastair Mark Thompson, Kathleen I. Pritchard, Timothy Joseph Whelan, Som D. Mukherjee, Haji I. Chalchal, Vanessa Bernstein, Vuk Stambolic, Bingshu E. Chen, Pamela Jean Goodwin

Clinical Trial

Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients

Yu Liu, Zhan-Yi Li, Jia-Ni Wang, Xi Li, Qun-Ai Huang, Yong Huang

Open Access Clinical trial

The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT)

Rachel L. O’Connell, Rosa Di Micco, Komel Khabra, Lisa Wolf, Nandita deSouza, Nicola Roche, Peter A. Barry, Anna M. Kirby, Jennifer E. Rusby

Open Access Clinical trial

Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

A. Sheri, I. E. Smith, M. Hills, R. L. Jones, S. R. Johnston, M. Dowsett

Clinical Trial

Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center

Antonella Petrillo, Roberta Fusco, Mario Sansone, Marilena Cerbone, Salvatore Filice, Annamaria Porto, Maria Rosaria Rubulotta, Massimiliano D’Aiuto, Franca Avino, Maurizio Di Bonito, Gerardo Botti

Clinical trial

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

Kunal C. Kadakia, Kelley M. Kidwell, Nicholas J. Seewald, Claire F. Snyder, Anna Maria Storniolo, Julie L. Otte, David A. Flockhart, Daniel F. Hayes, Vered Stearns, N. Lynn Henry

Open Access Clinical trial

Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials

Wilfried Krois, Alexander Ken Romar, Thomas Wild, Peter Dubsky, Ruth Exner, Peter Panhofer, Raimund Jakesz, Michael Gnant, Florian Fitzal

Epidemiology

Breast cancer treatment costs in younger, privately insured women

Benjamin T. Allaire, Donatus U. Ekwueme, Diana Poehler, Cheryll C. Thomas, Gery P. Guy Jr., Sujha Subramanian, Justin G. Trogdon

Open Access Epidemiology

The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results

D. A. Young-Afat, C. H. van Gils, H. J. G. D. van den Bongard, H. M. Verkooijen, S. A. Gernaat, M. L. Gregorowitsch, A. M. May, P. H. Peeters, C. C. van der Pol, A. J. Witkamp, R. M. Pijnappel, R. M. Bijlsma, W. Maarse, M. G. Ausems, P. J. van Diest, E. van der Wall, T. van Dalen, I. P. Burgmans, M. A. de Roos, R. C. van Doorn, I. O. Baas, B. van Ooijen, R. Koelemij

Open Access Epidemiology

A breast cancer gene signature for indolent disease

Leonie J. M. J. Delahaye, Caroline A. Drukker, Christa Dreezen, Anke Witteveen, Bob Chan, Mireille Snel, Inès J. Beumer, Rene Bernards, M. William Audeh, Laura J. van’t Veer, Annuska M. Glas

Epidemiology

Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case–control study in the EPIC Florence cohort

Giovanna Masala, Daniela Ambrogetti, Melania Assedi, Benedetta Bendinelli, Saverio Caini, Domenico Palli

Epidemiology

Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk

Su Yon Jung, Gloria Ho, Thomas Rohan, Howard Strickler, Jennifer Bea, Jeanette Papp, Eric Sobel, Zuo-Feng Zhang, Carolyn Crandall

Brief Report

Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome

Paola Concolino, Roberta Rizza, Karl Hackmann, Ida Paris, Angelo Minucci, Elisa De Paolis, Giovanni Scambia, Cecilia Zuppi, Evelin Schrock, Ettore Capoluongo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine